Program News
News and stories about members of the UNC Lineberger Cancer Prevention and Control Research Program
-
Digital health outreach improves lung cancer screening
A new multi-site study has demonstrated that a direct-to-patient digital health program can significantly increase recommended lung cancer screening for high-risk individuals.
-
UNC Lineberger faculty members presenting Het Talks during University Research Week
Three UNC Lineberger members will share their research during the Het Talks at UNC-Chapel Hill’s University Research Week, Oct. 20-24.
-
Researchers awarded $11.2M grant to close endometrial cancer survival gap
The National Cancer Institute has awarded a Cancer Health Disparities Specialized Program of Research Excellence (SPORE) in Endometrial Cancer grant to UNC Lineberger’s Victoria Bae-Jump, MD, PhD, and Hazel Nichols, PhD.
-
Oncology nursing fellowship graduates its 10th class
The UNC Lineberger-Sylvia Lauterborn and Warren Trent Piver Oncology Nursing Fellowship program celebrated its 10th anniversary and honored its latest class of fellows.
-
UNC Lineberger launches study to evaluate multi-cancer detection tests
UNC Lineberger is recruiting participants for the Vanguard Study, which is evaluating a new type of blood test that screens for several types of cancer. This is the first study of the Cancer Screening Research Network.
-
Graphic warnings on little cigars and cigarillos drive higher quit rates, UNC study shows
Adam Goldstein, MD, MPH, and colleagues report that graphic health warnings on little cigars and cigarillos significantly increase users’ intentions to quit and promote behaviors linked to tobacco cessation.
-
Stein discusses latest advances in sarcoma treatment, research
July is Sarcoma Awareness Month. Jake Stein, MD, MPH, shares that recent advances in targeted therapies, immunotherapy and radiation techniques are improving outcomes for patients diagnosed with this group of cancers.
-
UNC honors three cancer center members with 2025 Hettleman Prizes
Sarah Cohen, PhD, Marissa Hall, PhD, and Lindsey James, PhD, were awarded Hettleman Prizes, which recognizes UNC-Chapel Hill early-career faculty who exemplify groundbreaking and innovative research.
-
UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting
UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.
-
E-cigarette warnings lower vaping interest and raise quit intentions
E-cigarette warnings effectively discourage vaping without causing unintended consequences like increased cigarette smoking, according to a meta-analysis of 24 studies by UNC Lineberger’s Seth Noar, PhD, and colleagues.
-
UNC faculty and trainees to present at the world’s largest clinical cancer research meeting
UNC faculty and trainees will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.
-
UNC public service awards recognize Fort Bragg Public Health Partnership, Tylee Craft
The Carolina Center for Public Service honored two recipients with close ties to UNC Lineberger: the Fort Bragg Public Health Partnership and UNC student-athlete Tylee Craft.
-
Helping testicular cancer survivors navigate life after treatment
At UNC Lineberger, a dedicated testicular cancer survivorship program is helping patients move forward with confidence and support.
-
UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.
-
Immunotherapy and targeted therapy combination proves effective against metastatic colorectal cancer
UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer.